IL10 and arthritic joint disease: We have used the new humanized double-transgenic model of arthritis to test oral administration of the altered peptide ligand A12 peptide and to demonstrate that T cells found in the GALT tissues release IL-10 and IL-4 in response to a murine autoantigen [17].